List of Tables
Table 1. Global Agomelatine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Agomelatine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Agomelatine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Agomelatine Sales (M Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Agomelatine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Agomelatine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Agomelatine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Agomelatine Average Price (US$/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Agomelatine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Agomelatine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Agomelatine, Product Type & Application
Table 12. Global Key Manufacturers of Agomelatine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Agomelatine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Agomelatine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Agomelatine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Agomelatine Sales by Region (2020-2025) & (M Pcs)
Table 18. Global Agomelatine Sales Market Share by Region (2020-2025)
Table 19. Global Agomelatine Sales by Region (2026-2031) & (M Pcs)
Table 20. Global Agomelatine Sales Market Share by Region (2026-2031)
Table 21. Global Agomelatine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Agomelatine Revenue Market Share by Region (2020-2025)
Table 23. Global Agomelatine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Agomelatine Revenue Market Share by Region (2026-2031)
Table 25. North America Agomelatine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Agomelatine Sales by Country (2020-2025) & (M Pcs)
Table 27. North America Agomelatine Sales by Country (2026-2031) & (M Pcs)
Table 28. North America Agomelatine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Agomelatine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Agomelatine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Agomelatine Sales by Country (2020-2025) & (M Pcs)
Table 32. Europe Agomelatine Sales by Country (2026-2031) & (M Pcs)
Table 33. Europe Agomelatine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Agomelatine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Agomelatine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Agomelatine Sales by Region (2020-2025) & (M Pcs)
Table 37. Asia Pacific Agomelatine Sales by Region (2026-2031) & (M Pcs)
Table 38. Asia Pacific Agomelatine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Agomelatine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Agomelatine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Agomelatine Sales by Country (2020-2025) & (M Pcs)
Table 42. Latin America Agomelatine Sales by Country (2026-2031) & (M Pcs)
Table 43. Latin America Agomelatine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Agomelatine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Agomelatine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Agomelatine Sales by Country (2020-2025) & (M Pcs)
Table 47. Middle East and Africa Agomelatine Sales by Country (2026-2031) & (M Pcs)
Table 48. Middle East and Africa Agomelatine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Agomelatine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Agomelatine Sales (M Pcs) by Type (2020-2025)
Table 51. Global Agomelatine Sales (M Pcs) by Type (2026-2031)
Table 52. Global Agomelatine Sales Market Share by Type (2020-2025)
Table 53. Global Agomelatine Sales Market Share by Type (2026-2031)
Table 54. Global Agomelatine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Agomelatine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Agomelatine Revenue Market Share by Type (2020-2025)
Table 57. Global Agomelatine Revenue Market Share by Type (2026-2031)
Table 58. Global Agomelatine Price (US$/Pcs) by Type (2020-2025)
Table 59. Global Agomelatine Price (US$/Pcs) by Type (2026-2031)
Table 60. Global Agomelatine Sales (M Pcs) by Application (2020-2025)
Table 61. Global Agomelatine Sales (M Pcs) by Application (2026-2031)
Table 62. Global Agomelatine Sales Market Share by Application (2020-2025)
Table 63. Global Agomelatine Sales Market Share by Application (2026-2031)
Table 64. Global Agomelatine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Agomelatine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Agomelatine Revenue Market Share by Application (2020-2025)
Table 67. Global Agomelatine Revenue Market Share by Application (2026-2031)
Table 68. Global Agomelatine Price (US$/Pcs) by Application (2020-2025)
Table 69. Global Agomelatine Price (US$/Pcs) by Application (2026-2031)
Table 70. Servier Company Information
Table 71. Servier Description and Business Overview
Table 72. Servier Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
Table 73. Servier Agomelatine Product
Table 74. Servier Recent Developments/Updates
Table 75. Rovi Pharma Company Information
Table 76. Rovi Pharma Description and Business Overview
Table 77. Rovi Pharma Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
Table 78. Rovi Pharma Agomelatine Product
Table 79. Rovi Pharma Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
Table 83. Novartis Agomelatine Product
Table 84. Novartis Recent Developments/Updates
Table 85. Nectid Inc Company Information
Table 86. Nectid Inc Description and Business Overview
Table 87. Nectid Inc Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
Table 88. Nectid Inc Agomelatine Product
Table 89. Nectid Inc Recent Developments/Updates
Table 90. Jiangsu Haosen Pharmaceutical Group Company Information
Table 91. Jiangsu Haosen Pharmaceutical Group Description and Business Overview
Table 92. Jiangsu Haosen Pharmaceutical Group Agomelatine Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
Table 93. Jiangsu Haosen Pharmaceutical Group Agomelatine Product
Table 94. Jiangsu Haosen Pharmaceutical Group Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Agomelatine Distributors List
Table 98. Agomelatine Customers List
Table 99. Agomelatine Market Trends
Table 100. Agomelatine Market Drivers
Table 101. Agomelatine Market Challenges
Table 102. Agomelatine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Agomelatine
Figure 2. Global Agomelatine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Agomelatine Market Share by Type: 2024 & 2031
Figure 4. Serotonin 2C Agonist Product Picture
Figure 5. Melatonin Receptor 2 Agonist Product Picture
Figure 6. Melatonin Receptor 1 Agonist Product Picture
Figure 7. Serotonin Receptor Agonist Product Picture
Figure 8. Serotonin 2C Receptor Antagonist Product Picture
Figure 9. Global Agomelatine Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Agomelatine Market Share by Application: 2024 & 2031
Figure 11. Depression
Figure 12. Obsessive Compulsive Disorder
Figure 13. Sleep Disorders
Figure 14. Generalized Anxiety Disorder
Figure 15. Multiple Sclerosis
Figure 16. Systemic Traumatic Pain
Figure 17. Autism
Figure 18. Other
Figure 19. Global Agomelatine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Agomelatine Market Size (2020-2031) & (US$ Million)
Figure 21. Global Agomelatine Sales (2020-2031) & (M Pcs)
Figure 22. Global Agomelatine Average Price (US$/Pcs) & (2020-2031)
Figure 23. Agomelatine Report Years Considered
Figure 24. Agomelatine Sales Share by Manufacturers in 2024
Figure 25. Global Agomelatine Revenue Share by Manufacturers in 2024
Figure 26. Global 5 and 10 Largest Agomelatine Players: Market Share by Revenue in Agomelatine in 2024
Figure 27. Agomelatine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Global Agomelatine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 29. North America Agomelatine Sales Market Share by Country (2020-2031)
Figure 30. North America Agomelatine Revenue Market Share by Country (2020-2031)
Figure 31. U.S. Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Canada Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Europe Agomelatine Sales Market Share by Country (2020-2031)
Figure 34. Europe Agomelatine Revenue Market Share by Country (2020-2031)
Figure 35. Germany Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. France Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. U.K. Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Italy Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Russia Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Asia Pacific Agomelatine Sales Market Share by Region (2020-2031)
Figure 41. Asia Pacific Agomelatine Revenue Market Share by Region (2020-2031)
Figure 42. China Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Taiwan Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Indonesia Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Thailand Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Malaysia Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Philippines Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Latin America Agomelatine Sales Market Share by Country (2020-2031)
Figure 53. Latin America Agomelatine Revenue Market Share by Country (2020-2031)
Figure 54. Mexico Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Brazil Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Argentina Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Agomelatine Sales Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Agomelatine Revenue Market Share by Country (2020-2031)
Figure 59. Turkey Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Saudi Arabia Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. UAE Agomelatine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Global Sales Market Share of Agomelatine by Type (2020-2031)
Figure 63. Global Revenue Market Share of Agomelatine by Type (2020-2031)
Figure 64. Global Agomelatine Price (US$/Pcs) by Type (2020-2031)
Figure 65. Global Sales Market Share of Agomelatine by Application (2020-2031)
Figure 66. Global Revenue Market Share of Agomelatine by Application (2020-2031)
Figure 67. Global Agomelatine Price (US$/Pcs) by Application (2020-2031)
Figure 68. Agomelatine Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
